Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a minor release/version change with no visible impact to the study record details.
    Difference
    0.1%
    Check dated 2026-04-26T13:37:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T04:48:12.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:41:54.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:39:51.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive content changes to the study details are visible in the screenshots.
    Difference
    0.1%
    Check dated 2026-02-13T12:34:01.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    This study was terminated early due to changes in melanoma treatment, with termination dated 2026-01-29. The recruitment status 'Active, not recruiting' was removed from the record.
    Difference
    0.5%
    Check dated 2026-02-05T15:12:23.000Z thumbnail image

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.